Melatonin metabolism in health and disease of the gastrointestinal tract (literature review)
- Авторлар: Musaeva L.N.1, Esedov E.M.1, Abasova A.S.1, Mammaev S.N.1
-
Мекемелер:
- Dagestan State Medical University of the Ministry of Healthcare of Russia
- Шығарылым: Том 7, № 7 (2021)
- Беттер: 144-151
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288501
- DOI: https://doi.org/10.18565/therapy.2021.7.144-151
- ID: 288501
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Luiza Musaeva
Dagestan State Medical University of the Ministry of Healthcare of Russiapostgraduate student, senior laboratory assistant of the Department of hospital therapy No. 2
Esed Esedov
Dagestan State Medical University of the Ministry of Healthcare of RussiaMD, professor, head of the Department of hospital therapy No. 2
Albina Abasova
Dagestan State Medical University of the Ministry of Healthcare of RussiaPhD, associate professor of the Department of hospital therapy No. 2
Suleiman Mammaev
Dagestan State Medical University of the Ministry of Healthcare of RussiaMD, professor, head of the Department of hospital therapy No. 1
Әдебиет тізімі
- Zaki N.F.W., Spence D.W., Subramanian P. et al. Basic chronobiology: what do sleep physicians need to know? Sleep Sci. 2020; 13(4): 256-66. doi: 10.5935/1984-0063.20200026.
- Семенова Н.В. Хронобиологические аспекты нарушений сна у женщин климактерического периода: роль мелатонина (обзор литературы). Acta biomedica scientifica (East Siberian Biomedical Journal). 2017; 5-1: 32-37. https://doi.org/10.12737/article_59e71aad2aa777.29348772.
- Chitimus D.M., Popescu M.R., Voiculescu S.E. et al. Melatonin's impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 2020; 10(9): 1211. doi: 10.3390/biom10091211.
- Oxlund J., Knudsen T., Strom T. et al. Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation. Ann Intensive Care. 2021; 11(1): 40. doi: 10.1186/s13613-021-00829-1.
- Bang C.S., Yang Y.J., Baik G.H. Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(4): e14241. doi: 10.1097/MD.0000000000014241.
- Xie S., Fan W., He H., Huang F. Role of melatonin in the regulation of pain. J. Pain Res. 2020; 13: 331-43. doi: 10.2147/JPR.S228577.
- Hardeland R. Divergent importance of chronobiological considerations in high- and low-dose melatonin therapies. Diseases. 2021; 9(1): 18. doi: 10.3390/diseases9010018.
- Socaciu A.I., Ionut R., Socaciu M.A. et al. Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases. Rev Endocr Metab Disord. 2020; 21(4): 465-78. doi: 10.1007/s11154-020-09570-9.
- Slominski A.T., Zmijewski M.A., Semak I. et al. Melatonin, mitochondria, and the skin. Cell Mol Life Sci. 2017; 74(21): 3913-25. doi: 10.1007/s00018-017-2617-7.
- Pires-Lapa M.A., Carvalho-Sousa C.E., Cecon E. et al. Beta-adrenoceptors trigger melatonin synthesis in phagocytes. Int J. Mol Sci. 2018; 19(8): 2182. doi: 10.3390/ijms19082182.
- Cipolla-Neto J., Amaral F., Afeche S. et al. Melatonin, energy metabolism, and obesity: A review. J. Pineal Res. 2014; 56(4): 371-81. doi: 10.1111/jpi.12137.
- Арушанян Э.Б., Ованесов К.Б. Значение мелатонина для физиологии и патологии глаза. Медицинский вестник Северного Кавказа. 2016; 1: 126-133. doi: https://doi.org/10.14300/mnnc.2016.11017.
- Xia Y., Chen S., Zeng S. et al. Melatonin in macrophage biology: current understanding and future perspectives. J. Pineal Res. 2019; 66(2): e12547. doi: 10.1111/jpi.2019.66.issue-2.
- Xiao L., Hu J., Song L. et al. Profile of melatonin and its receptors and synthesizing enzymes in cumulus-oocyte complexes of the developing sheep antral follicle-a potential estradiol-mediated mechanism. Reprod Biol Endocrinol. 2019; 17(1): 1. doi :10.1186/ s12958-018-0446-7.
- Esteban-Zubero E., Lopez-Pingarron L., Alatorre-Jimenez M.A. et al. Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Life Sci. 2017; 170: 72-81. doi: 10.1016/j.lfs.2016.11.031.
- Mehrzadi S., Pourhanifeh M.H., Mirzaei A. et al. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. Cancer Cell Int. 2021; 21(1): 188. doi: 10.1186/s12935-021-01892-1.
- Xie W.Q., Chen S.F., Tao X.H. et al. Melatonin: Effects on cartilage homeostasis and therapeutic prospects in cartilage-related diseases. Aging and Disease. 2021; 12(1): 297-307. doi: 10.14336/ad.2020.0519.
- Boutin J.A., Ferry G. Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2? J. Pharmacol Exp Ther. 2019; 368(1): 59-65. doi: 10.1124/jpet.118.253260.
- Cecon E., Oishi A., Jockers R. Melatonin receptors: Molecular pharmacology and signalling in the context of system bias. Br J. Pharmacol. 2018; 175(16): 3263-80. doi: 10.1111/bph.13950.
- Posa L., De Gregorio D., Gobbi G., Comai S. Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Curr Med Chem. 2018; 25(32): 3866-82. doi: 10.2174/0929867324666170209104926
- Cook D.N., Kang H.S., Jetten A.M. Retinoic acid-related orphan receptors (RORs): Regulatory functions in immunity, development, circadian rhythm, and metabolism. Nucl Receptor Res. 2015; 2: 101185. doi: 10.11131/2015/101185.
- Liu L., Labani N., Cecon E., Jockers R. Melatonin target proteins: Too many or not enough? Front Endocrinol (Lausanne). 2019; 10: 791. doi: 10.3389/fendo.2019.00791.
- Курганова Ю.М., Данилов А.Б. Роль мелатонина в терапии хронической головной боли. МС. 2018; 1: 33-37. doi: https://doi.org/10.21518/2079-701X-2018-1-33-37.
- Арушанян Э.Б., Бейер Э.В. Мелатонин: биология, фармакология, клиника. Монография. Ставрополь. 2015; 390 с.
- Арушанян Э.Б., Щетинин Е.В. Мелатонин как универсальный модулятор любых патологических процессов. Патологическая физиология и экспериментальная терапия. 2016; 1: 79-88.
- Reiter R.J., Mayo J.C., Tan D.X. et al. Melatonin as an antioxidant: Under promises but over delivers. J. Pineal Res. 2016; 61(3): 253-78. doi: 10.1111/jpi.12360.
- Tan D.X., Manchester L.C., Qin L., Reiter R.J. Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int J. Mol Sci. 2016; 17(12): 2124. doi: 10.3390/ijms17122124.
- Huo X., Wang C., Yu Z. et al. Human transporters, PEPT1/2, facilitate melatonin transportation into mitochondria of cancer cells: an implication of the therapeutic potential. J. Pineal Res. 2017; 62(4). doi: 10.1111/jpi.12390.
- Mayo J.C., Sainz R.M., Gonzalez-Menendez P. et al. Melatonin transport into mitochondria. Cell Mol Life Sci. 2017; 74(21): 3927-40. doi: 10.1007/s00018-017-2616-8.
- Bonmati-Carrion M.A., Tomas-Loba A. Melatonin and cancer: A polyhedral network where the source matters. Antioxidants (Basel). 2021; 10(2): 210. doi: 10.3390/antiox10020210.
- Bai J., Zhang L., Zhao Z. et al. Expression of melatonin receptors and CD4 in the ovine thymus, lymph node, spleen and liver during early pregnancy. Immunology. 2020; 160(1): 52-63. doi: 10.1111/imm.13180.
- Hardeland R. Divergent importance of chronobiological considerations in high- and low-dose melatonin therapies. Diseases. 2021; 9(1): 18. doi: 10.3390/diseases9010018.
- Borniger J.C., Cisse Y.M., Surbhi, Nelson R.J. Reciprocal regulation of circadian rhythms and immune function. Curr Sleep Medicine Rep. 2007; 3: 93-103. doi: 10.1007/s40675-017-0070-7.
- Tordjman S., Chokron S., Delorme R. et al. Melatonin: Pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017; 15(3): 434-43. doi: 10.2174/1570159X14666161228122115.
- Nabavi S.M., Nabavi S.F., Sureda A. et al. Anti-inflammatory effects of melatonin: A mechanistic review. Crit Rev Food Sci Nutr. 2018; 59(Suppl 1): 4-16. doi: 10.1080/10408398.2018.1487927.
- Liu Z., Gan L., Xu Y. et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-KB/GSDMD signal in mice adipose tissue. J. Pineal Res. 2017; 63(1). doi: 10.1111/jpi.12414.
- Su S.C., Hsieh M.J., Yang W.E. et al. Cancer metastasis: mechanisms of inhibition by melatonin. J. Pineal Res. 2017; 62(1): e12370. doi: 10.1111/jpi.12370.
- Gurunathan S., Qasim M., Kang M.H., Kim J.H. Role and therapeutic potential of melatonin in various type of cancers. Onco Targets Ther. 2021; 14: 2019-52. doi: 10.2147/ott.s298512.
- Colombo J., Maciel J.M., Ferreira L.C. et al. Effects of melatonin on HIF-1a and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncol Lett. 2016; 12(1): 231-37. doi: 10.3892/ol.2016.4605.
- Kim H.B., Kim J.H. Sunlight exposure in association with risk of lymphoid malignancy: a meta-analysis of observational studies. Cancer Causes Control. 2021; 32(5): 441-57. doi: 10.1007/s10552-021-01404-6.
- Kvietkauskas M., Zitkute V., Leber B. et al. The role of melatonin in colorectal cancer treatment: a comprehensive review. Ther Adv Med Oncol. 2020; 12: 1758835920931714. doi: 10.1177/1758835920931714.
- Mayo J.C., Sainz R.M. Melatonin from an antioxidant to a classic hormone or a tissue factor: Experimental and clinical aspects 2019. Int J. Mol Sci. 2020; 21(10): 3645. doi: 10.3390/ijms21103645.
- Kopustinskiene D.M., Bernatoniene J. Molecular mechanisms of melatonin-mediated cell protection and signaling in health and disease. Pharmaceutics. 2021; 13(2): 129. doi: 10.3390/pharmaceutics13020129.
- Циммерман Я.С. Стойкие заблуждения современной гастроэнтерологии. Клиническая фармакология и терапия. 2016; 5: 5-13.
- Ивашкин В.Т., Маев И.В., Царьков П.В. с соавт. Диагностика и лечение язвенной болезни у взрослых (Клинические рекомендации Российской гастроэнтерологической ассоциации, Российского общества колоректальных хирургов и Российского эндоскопического общества). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020; 1: 49-70. doi: https://doi.org/10.22416/1382-4376-2020-30-1-49-70.
- Григорьев К.И., Запруднов А.М., Харитонова А.А. Язвенная болезнь - историческая динамика взглядов на этиопатогенез и лечение с позиций педиатров. Экспериментальная и клиническая гастроэнтерология. 2019; 1: 1 55-165. doi: https://doi.org/10.31146/1682-8658-ecg-161-1-155-165.
- Волкова Н.И., Джериева И.С. Гастроэнтерология: учебное пособие. Ростов-на-Дону: Издательство РостГМУ. 2016; 161 с.
- Циммерман Я.С. Язвенная болезнь: критический анализ современного состояния проблемы. Экспериментальная и клиническая гастроэнтерология. 2018; 1: 80-89.
- Ahmed S., Belayneh Y.M. Helicobacter pylori and duodenal ulcer: systematic review of controversies in causation. Clin Exp Gastroenterol. 2019; 12: 441-47. doi: 10.2147/CEG.S228203.
- Li R., Boer C.G., Oei L., Medina-Gomez C. The gut microbiome: A new frontier in musculoskeletal research. Curr Osteoporos Rep. 2021; 19(3): 347-57. doi: 10.1007/s11914-021-00675-x.
- Shimizu Y. Gut microbiota in common elderly diseases affecting activities of daily living. World J. Gastroenterol. 2018; 24(42): 4750-58. doi: 10.3748/wjg.v24.i42.4750.
- Самойлова Ю.Г., Олейник О.А., Саган Е.В. с соавт. Состав и метаболическая активность микробиоты пищеварительной системы у детей и подростков с ожирением. Сибирский журнал клинической и экспериментальной медицины. 2020; 3: 38-46. doi: https://doi.org/10.29001/2073-8552-2020-35-3-38-46.
- Litovskij I.A., Gordienko A.V. Anti-Helicobacter pylori eradication therapy - a way out of the impasse or moving deeper into the labyrinth? Clin Pharmacol Ther. 2018; 27(5): 11-16. doi: 10.32756/0869-5490-2018-5-11-16.
- Циммерман Я.С., Захарова Ю.А. Киотский консенсус - новая этиологическая классификация хронического гастрита и ее обсуждение. Клиническая медицина. 2017; 2: 181-188. doi: http://dx.doi.org/10.18821/0023-2149-2017-95-2-181-188.
- Циммерман Я.С. Антибактериальная терапия и ее влияние на эндоэкологическую систему «макроорганизм - эндосимбионтные бактерии» (на примере Helicobacter pylori-ассоциированных заболеваний). Клиническая фармакология и терапия. 2015; 2: 5-12.
- Червинец В.М., Червинец Ю.В., Базлов С.Н. Микробиом эзофагогастродуоденальной зоны здоровых людей и при воспалительно-эрозивно-язвенных ее поражениях. Бюллетень Оренбургского научного центра УРО РАН. 2019; 3: 26.
- Хижкин Е.А., Илюха В.А., Виноградова И.А. Перестройки пищеварительной функции крыс, вызванные длительным постоянным освещением. Российский физиологический журнал им. И.М. Сеченова. 2018; 2: 238-247. doi: https://doi.org/10.1134/S0869813919020055.
- Hunter C.M., Figueiro M.G. Measuring light at night and melatonin levels in shift workers: A review of the literature. Biol Res Nurs. 2017; 19(4): 365-74. doi: 10.1177/1099800417714069.
- Lu X., Yu S., Chen G. et al. Insight into the roles of melatonin in bone tissue and bone related diseases (Review). Int J. Mol Med. 2021; 47(5): 82. doi: 10.3892/ijmm.2021.4915
- Acuna-Castroviejo D., Escames G., Venegas C. et al. Extra pineal melatonin: Sources, regulation, and potential functions. Cell Mol Life Sci. 2014; 71(16): 2997-3025. doi: 10.1007/s00018-014-1579-2.
- Jaworek J., Leja-Szpak A., Nawrot-Porabka K. et al. Effects of melatonin and its analogues on pancreatic inflammation, enzyme secretion, and tumorigenesis. Int J. Mol Sci. 2017; 18(5): 1014. doi: 10.3390/ijms18051014.
- Вапаев К.Б., Ирназаров Ш.О. Роль мелатонина в регуляции функции желудочно-кишечного тракта. Современные инновации. 2019; 1: 32-35.
- Chojnacki C., Medrek-Socha M., Konrad P. et al. The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia. BMC Women's Health. 2020; 20(1): 262. doi: 10.1186/s12905-020-01117-z.
- Favero G., Franceschetti L., Bonomini F. et al. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J. Endocrinol. 2017; 2017: 1835195. doi: 10.1155/2017/1835195.
- Andersen L.P.H., Gogenur I., Rosenberg J., Reiter R.J. The safety of melatonin in humans. Clin. Drug Investig. 2015; 36(3): 169-75. doi: 10.1007/s40261-015-0368-5.
- Baburina Y., Lomovsky A., Krestinina O. Melatonin as a potential multitherapeutic agent. J. Pers Med. 2021; 11(4): 274. doi: 10.3390/ jpm11040274.
- He F., Wu X., Zhang Q. et al. Bacteriostatic potential of melatonin: Therapeutic standing and mechanistic insights. Front Immunol. 2021; 12: 683879. doi: 10.3389/fimmu.2021.683879.
- Ford A.C., Gurusamy K.S., Delaney B. et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016; 4(4): CD003840. doi: 10.1002/14651858.CD003840.pub5.
- Li L., Zhao Z., Ma J. et al. Elevated plasma melatonin levels are correlated with the non-motor symptoms in Parkinson's disease: A cross-sectional study. Front Neurosci. 2020; 14: 505. doi: 10.3389/fnins.2020.00505. eCollection 2020.
Қосымша файлдар
![](/img/style/loading.gif)